Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Tetaz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Transplantation|June 13, 2012
Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICTSebastien Dharancy, Magali Giral, Rachel Tetaz, et al.
Case Reports in Oncology|May 12, 2021
Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib TherapiesQuentin Perrier, Johan Noble, Steven Grangé, et al.
Case Reports in Nephrology|November 6, 2019
Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case SeriesHamza Naciri Bennani, Thomas Jouve, Johan Noble, et al.
Therapie|May 23, 2018
Severe acute hepatitis after thymoglobulin induction before islet transplantationQuentin Perrier, Rachel Tetaz, Magalie Baudrant, et al.
Annals of Transplantation|September 29, 2012
Predictive diagnostic of chronic allograft dysfunction using urinary proteomics analysisRachel Tetaz, Candice Trocmé, Mathieu Roustit, et al.
Nephrologie & Therapeutique|November 16, 2019
[The contribution of an ethical concertation group in nephrology validated by a research protocol]Jocelyne Maurizi-Balzan, Éric Fourneret, Laurence Cimar, et al.
Case Reports in Nephrology and Dialysis|March 12, 2021
A Case of <i>Pneumocystis jirovecii</i> Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and InfectionQuentin Perrier, Antoine Portais, Florian Terrec, et al.
Transplantation Proceedings|November 17, 2019
Early Prediction of Graft Outcomes After Kidney Transplantation From Donors After Circulatory Death: Biomarkers and Transplantation CharacteristicsAnne-Sophie Truche, Candice Trocme, Sabrina Vergnaud, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 23, 2018
Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant PatientsMorgane Villemaire, Thomas Jouve, Anne Bourdin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 2, 2014
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodiesLaure-Emmanuelle Croze, Rachel Tetaz, Matthieu Roustit, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Transplantation|June 13, 2012
Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICTSebastien Dharancy, Magali Giral, Rachel Tetaz, et al.
Case Reports in Oncology|May 12, 2021
Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib TherapiesQuentin Perrier, Johan Noble, Steven Grangé, et al.
Case Reports in Nephrology|November 6, 2019
Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case SeriesHamza Naciri Bennani, Thomas Jouve, Johan Noble, et al.
Therapie|May 23, 2018
Severe acute hepatitis after thymoglobulin induction before islet transplantationQuentin Perrier, Rachel Tetaz, Magalie Baudrant, et al.
Annals of Transplantation|September 29, 2012
Predictive diagnostic of chronic allograft dysfunction using urinary proteomics analysisRachel Tetaz, Candice Trocmé, Mathieu Roustit, et al.
Nephrologie & Therapeutique|November 16, 2019
[The contribution of an ethical concertation group in nephrology validated by a research protocol]Jocelyne Maurizi-Balzan, Éric Fourneret, Laurence Cimar, et al.
Case Reports in Nephrology and Dialysis|March 12, 2021
A Case of <i>Pneumocystis jirovecii</i> Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and InfectionQuentin Perrier, Antoine Portais, Florian Terrec, et al.
Transplantation Proceedings|November 17, 2019
Early Prediction of Graft Outcomes After Kidney Transplantation From Donors After Circulatory Death: Biomarkers and Transplantation CharacteristicsAnne-Sophie Truche, Candice Trocme, Sabrina Vergnaud, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 23, 2018
Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant PatientsMorgane Villemaire, Thomas Jouve, Anne Bourdin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 2, 2014
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodiesLaure-Emmanuelle Croze, Rachel Tetaz, Matthieu Roustit, et al.
Pageof 2